Drug Clinical Trials List

Share page

Display 371 - 380 from 730
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma Novartis Terminated QAW039/Fevipiprant 3 CQAW039A2315 KFMC
A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma Novartis Terminated QAW039/Fevipiprant 3 CQAW039A2315 KFMC
A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants Novartis Completed Everolimus + reduced tacrolimus VS.Tacrolimus 3 CRAD001H2307 KFSH & RC-R
“MERS-CoV Infection Treated with a Combination of Lopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-Blind Randomized Trial (MIRACLE Trial)” KAIMRC Completed Kaletra 3 RC15/142/R NGHA-R
"RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity" Novartis Completed Ranibizumab 3 CRFB002H2301E1 KFSH & RC-R
Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection Janssen-Cilag International NV Completed TMC435 (simeprevir) 3b TMC435HPC3014 KFSH & RC-R
An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction Roche Terminated Trastuzumab SC 3b ML28851 KKUH (Closed)
An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women 3
A RANDOMIZED, PARTIALLY-BLIND, PLACEBO-CONTROLLED, PILOT, DOSE-RANGING STUDY TO ASSESS THE EFFECT OF GWP42003 ON LIVER FAT LEVELS IN SUBJECT WITH FATTY LIVER DISEASE GW Rejected Cannabidiol 2a GWZMD1188 KKUH
A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus MSD Terminated MK-0431A (Sitagliptin / Metformin) vs Liraglutide 3 MK-0431A-180-00 KKUH


هل استفدت من ما هو مقدم في هذه الصفحة؟
0 من الزوار ردوا بنعم من أصل0 مشاركة
السبب
السبب